Press release
Palatin Technologies' UC Treatment Shows Remarkable 78% Clinical Response Rate in Phase 2 Topline Data - Potential Game-Changer for Millions Suffering from Ulcerative Colitis (NYSE: PTN)
Palatin Technologies (NYSE American: PTN)* just unveiled remarkable topline results from its Phase 2 study of PL8177 for ulcerative colitis (UC), demonstrating what could be a disruptive new treatment approach for this debilitating inflammatory bowel condition.
The data seems impressive - an extraordinary 78% of patients treated with PL8177 achieved clinical response compared to just 33% for placebo, with statistical significance (p
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Palatin Technologies' UC Treatment Shows Remarkable 78% Clinical Response Rate in Phase 2 Topline Data - Potential Game-Changer for Millions Suffering from Ulcerative Colitis (NYSE: PTN) here
News-ID: 3947959 • Views: …
More Releases from ABNewswire
Caliente Brands Targets Niche Spice Market with Hickory-Smoked Beef Jerky Line F …
Caliente Brands, LLC capitalizes on growing consumer demand for authentically spicy snacks with a specialized beef jerky line that puts heat first. Using only 100% USDA Approved Beef and hickory smoking techniques, the veteran-owned company offers distinctive flavors including innovative Spicy Birria alongside traditional options, all designed to deliver the brand promise that smoky and spicy meet delicious.
Caliente Brands, LLC has strategically positioned itself to serve a niche but substantial…
Manaslu Circuit Trek Offers the Real Taste of Wilderness Adventure in the Himala …
Kathmandu, Nepal - Peace Nepal Treks announces expanded departures for the Manaslu Circuit Trek, a high Himalayan journey known for raw landscapes, cultural depth, and challenging terrain. This route delivers a true wilderness experience for trekkers seeking remote adventure beyond crowded trails.
The Manaslu Circuit Trek encircles Mount Manaslu at 8,163 meters, the eighth highest peak on Earth. The trail crosses Larke Pass at 5,106 meters and moves through steep gorges,…
Custom Cardboard Boxes: Complete Buyer Guide
Image: https://www.abnewswire.com/upload/2026/02/0f0fee39afaa0d25711f34ee831a6f6f.jpg
Packaging protects merchandise and shapes first impressions. It additionally impacts transport value, and consumers agree with it. In today's market, brands need packaging that is strong, flexible, and affordable. This is where custom cardboard packing boxes play a crucial role.
Custom cardboard boxes [https://www.thecustomboxes.com/cardboard-boxes/] are used by small groups and large brands alike. They paint retail shelves, online orders, and warehouse garages. They are easy to print, smooth to recycle,…
Mondressy Unveils Its 2026 Defining Colors: The Five Essential Shades of "Matria …
Top 5 color palettes for 2026 spotlight navy blue, champagne, black, dark green, and burgundy for the modern mother-of-the-occasion wardrobe.
Mondressy has officially introduced its 2026 defining colors, identifying five essential shades that embody what the brand calls "Matriarchal Authority and Elegance." The brand's 2026 color direction centers on navy blue, champagne, black, dark green, and burgundy, a five-color foundation designed for mother-of-the-bride dresses [https://mondressy.com/collections/mother-of-the-bride-dresses] to help mothers step into milestone…
More Releases for Palatin
Moderate Dry Eye Market Growth to Accelerate in Forecast Period (2023-2032), Del …
The Key Moderate Dry Eye Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Moderate Dry Eye market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Moderate Dry Eye pipeline products will significantly revolutionize the Moderate Dry Eye market dynamics.
DelveInsight's "Moderate Dry Eye Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding…
Mild Dry Eye Market Growth Projections 2023-2032: DelveInsight Analysis | Palati …
The Key Mild Dry Eye Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Mild Dry Eye market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Mild Dry Eye pipeline products will significantly revolutionize the Mild Dry Eye market dynamics.
DelveInsight's "Mild Dry Eye Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding…
Dry Eye Disease Market Growth Projections 2024-2034: DelveInsight Analysis | Pal …
The Key Dry Eye Disease Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Dry Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye Disease market dynamics.
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding…
Dry Eye Disease Market to Expand Significantly by 2034, States DelveInsight Repo …
The Dry Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye Disease market dynamics.
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Dry Eye Disease, historical and forecasted epidemiology as well as the Dry Eye…
Palatin Technologies' Obesity Drug Receives FDA Orphan Designation; Phase 2 Resu …
Palatin Technologies (NYSE: PTN)* and their latest developments: Palatin's Oral MC4R Agonist Gets FDA Orphan Drug Status; Phase 2 Results in Drug Targeting $44 Billion Obesity Market Expected Any Day According to the Company, alongside results from ulcerative colitis trial; Only Oral Option in Market Currently Dominated by Injections Uniquely Positioning Palatin
In an exciting development for the biopharma market, Palatin Technologies (NYSE: PTN)* announced that it has secured FDA orphan…
Dry Eye Disease Market to Show Incremental Growth, asserts DelveInsight | Promin …
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Dry Eye Disease, historical and forecasted epidemiology as well as the Dry Eye Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Dry Eye Disease market report provides current treatment practices, emerging drugs, Dry Eye Disease market share of the individual therapies, current and forecasted…
